探讨人工肝支持系统治疗药物性肝病的临床疗效及安全性

目的：评估药物性肝病救治中选择人工肝支持系统的安全性与有效性。方法方便选取2014年5月—2016年5月因药物性肝病于该院治疗的66例患者，对其随机分组，治疗组34例常规护肝药物加人工肝支持治疗，对照组32例常规疗法，比对血清生化指标。结果治疗组病例有效率94.12%(32/34)，对照组病例有效率75.00%(24/32)，差异有统计学意义(P﹤0.05)。结论对药物性肝病患者进行救治时，选择人工肝支持系统疗效显著。

Artificial Liver Support System Treatment the Clinical Curative Effect and Security of the Liver Disease

Objective To evaluate drug-induced liver disease treatment selection of artificial liver support system in the safety and effectiveness. Methods Convenient selection in May 2014 to May 2016 because of drug-induced liver disease in our hospital treatment of 66 patients, the group, treatment group (34 cases of conventional protect liver medicine plus artifi-cial liver support therapy, the control group, 32 cases of conventional therapy, comparing the serum biochemical indicators. Results Cases in treatment group effective rate was 94.12% (32/34), effective rate was 75.00% (24/32) in the control group cases.the treatment group serum biochemical index to improve the quality is superior to the basic group,the difference was statistically significant. (P< 0.05). Conclusion To treat patients with drug-induced liver disease, the selection of artificial liver support system curative effect is remarkable.